Last updated: November 20, 2023
Sponsor: Radicle Science
Overall Status: Completed
Phase
N/A
Condition
Depression
Pain
Treatment
Health Active Study Product 1.1 Capsules
Placebo Control Form 1 Capsules
Health Active Study Product 1.3 Capsules
Clinical Study ID
NCT05783232
RADX-22D07
Ages 21-105 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 21 years of age and older
- Resides in the United States
- Endorses: a desire for better sleep and/or focus, less pain, less feelings of stress,depression, and/or anxiety, and/or more energy (less fatigue)
- Expresses a willingness to take a study product that may contain cannabinoids (orplacebo) and not know the product identity until the end of the study
Exclusion
Exclusion Criteria:
- Reports being pregnant, trying to become pregnant, or breastfeeding
- Unable to provide a valid physical shipping address and mobile phone number
- Reports a diagnosis of liver or kidney disease
- Reports being a heavy drinker (defined as drinking 3 or more alcoholic beverages perday)
- Reports current enrollment in a clinical trial
- The QOL score greater than 5 during enrollment
- Unable to read and understand English
- Lack of reliable daily access to the internet
- Reports taking any medication that warns against grapefruit consumption
- Reports current or recent (within 3 months) use of chemotherapy, immunotherapy, ororal anti-infectives (antibiotics, antifungals, antivirals) to treat an acuteinfection
Study Design
Total Participants: 1494
Treatment Group(s): 4
Primary Treatment: Health Active Study Product 1.1 Capsules
Phase:
Study Start date:
March 21, 2023
Estimated Completion Date:
October 27, 2023
Study Description
Connect with a study center
Radicle Science, Inc
Del Mar, California 92014
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.